UNICREDIT BANK/PUT/BIOGEN IDEC/200/0.1/15.01.25 | Market Closed - BOERSE MUENCHEN 03:42:15 2024-07-12 pm EDT | ||
| 0.82 EUR | +17.14% |
|
| Current month | -11.83% | ||
| 1 month | -14.58% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 0.82 | +17.14% |
| 24-07-11 | 0.7 | -11.39% |
| 24-07-10 | 0.79 | -8.14% |
| 24-07-09 | 0.86 | -1.15% |
| 24-07-08 | 0.87 | -6.45% |
Real-time BOERSE MUENCHEN
Last update July 12, 2024 at 03:42 pm EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD0NWS |
| ISIN | DE000HD0NWS6 |
| Date issued | 2023-11-13 |
| Strike | 200 $ |
| Maturity | 2025-01-15 (187 Days) |
| Parity | 10 : 1 |
| Emission price | 1.78 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.42 € |
|---|---|
| Lowest since issue | 0.69 € |
| Spread | 0.01 € |
| Spread % | 1.23% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
230.1
USD
Average target price
281.3
USD
Spread / Average Target
+22.27%
- Stock Market
- Warrants
- Warrant
